News

Tesla’s TSLA car sales dropped significantly in several European countries in May, which marks the fifth straight month of ...
Drivers are encouraged by this EV sales momentum. Tesla defies national slump with breakout success in key market: 'Actual ...
BioNTech and Bristol Myers Squibb have agreed to jointly develop and commercialize BioNTech's BNT327 cancer-drug candidate in a deal potentially worth more than $11 billion to the German drugmaker.
BioNTech and Bristol Myers Squibb have agreed to jointly develop and commercialize BioNTech's BNT327 cancer-drug candidate in a deal potentially worth more than $11 billion to the German drugmaker.